Welcome to JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES) May 23, 2025
Volume 48 Issue 6
Nov.  2017
Turn off MathJax
Article Contents
ZHONG Hang, CAO Can, YANG Jing. et al. Research on Relationship of HIF-1 Signaling Pathway and Postmenstrual Osteoporosis[J]. Journal of Sichuan University (Medical Sciences), 2017, 48(6): 862-868.
Citation: ZHONG Hang, CAO Can, YANG Jing. et al. Research on Relationship of HIF-1 Signaling Pathway and Postmenstrual Osteoporosis[J]. Journal of Sichuan University (Medical Sciences), 2017, 48(6): 862-868.

Research on Relationship of HIF-1 Signaling Pathway and Postmenstrual Osteoporosis

More Information
  • Published Date: November 19, 2017
  • ObjectiveExploring the role of hypoxia-induceibal factor-1 (HIF-1) signaling pathway in postmenstrual osteoporosis (PMOP) and how to play a role in PMOP. MethodsSixty C57BL/6J female mouse were randomly divided into 4 groups: sham-operation group (A group), ovariectomized PMOP group (B group), HIF-1 alpha inhibitor 2-methoxy estradiol (2ME2) treatment group(D group) and solvent control group(C group), 15 mice in each group. There months after modeling, the metabolism product of mouse bone tissue including serum propeptide of typeⅠ procollagen (PINP), C-terminal telopeptide-Ⅰ (CTX-1) and serum estrogen were quantified by enzyme-linked immunosorbent assay (ELISA). Changes of bone structure were observed on HE stained tissue sections. Regulation products of HIF-1 signaling pathway including HIF-1α, HIF-1β, specific prolyl hydroxylases (PHD), Hipple-Lindau tumor suppressor protein (VHL), and factor inhibiting HIF (FIH) were measured by immuno-histochenmistry staining. Osteoclasts derived from OVX-mice were treated with inhibitors of extracellular regulated protein kinases (ERK), protein kinase B (Akt) and nuclear factor kappa B (NF-κB) signaling pathways. HIF-1α expression were detected by Western blot to obtain a rudimentary knowledge of possible mechanism of up-regulation of HIF-1α in osteoclasts of postmenospausal osteoporosis. ResultsMetabolism product of mouse bone tissue of B group were higher than A group ( P<0.001). The positive expression of HIF-1-alpha protein was found in osteoclasts, and the expression of HIF-1-alpha protein in bone marrow region was higher than that in A group ( P<0.001), while the change od HIF-1β, PHD, VHL, and FIH were not obviously. After the HIF-1α inhibitor treatment, markers of bone resorption of bone metabolism in ovariectomized mice reduced and the osteoporosis get greatly relieved ( P<0.001). HIF-1α expression was down-regulated in osteoclasts of OVX-mice after treated with inhibitors of ERK, Akt and NF-κB signaling pathways ( P<0.05). ConclusionHIF-1 signaling pathway get involved in the pathological evolution of osteoporosis after menopause, and inhibition of HIF-1 can significantly improve the severity of osteoporosis after menopause. ERK, Akt and NF-κB signaling pathways may involve in the up-regulation of HIF-1 signaling pathway in osteoclasts of PMOP.
  • Cited by

    Periodical cited type(32)

    1. 迟皓南,孙小慧,杨毅. 基于网络药理学的二仙汤“异病同治”乳腺增生和围绝经期综合征的作用机制. 西部中医药. 2024(01): 80-87 .
    2. 王炯博,廖柳,于晓明,樊婷,贺柏华,王慧萍. 基于网络药理学探讨加味二至丸“异病同治”绝经综合症和原发性失眠的作用机制. 云南中医中药杂志. 2024(03): 52-63 .
    3. 崔晨辉,杜巧婷,刘令令. 基于网络药理学及分子对接探讨安度更年丸治疗围绝经期综合征的作用机制. 中医学报. 2023(01): 161-169 .
    4. 赵秀萍,马小娜,郭亚楠. 基于网络药理学及实验研究探究坤泰胶囊异病同治卵巢早衰及绝经综合征作用机制. 世界中医药. 2023(14): 1945-1951 .
    5. 李孟莹,刘子维,栗俞程,权建野,聂颖兰,张海鸣,张美玉,练晓梅,杨丽,胡文青,孙健. UPLC-Q-TOF-MS~E整合网络药理学研究丹栀逍遥方入血成分及其治疗围绝经期抑郁症的作用机制. 中国中药杂志. 2023(24): 6765-6777 .
    6. 卢博文,韩静,魏艳. 左归丸治疗骨质疏松症:可能的分子机制及生物学过程. 中医临床研究. 2023(35): 10-16 .
    7. 刘朋,杨鸫祥,于冬冬,王秀婷. 基于网络药理学探讨龟鹿二仙胶治疗骨质疏松症的作用机制. 海南医学院学报. 2022(03): 216-224 .
    8. 左静,冯云霞,李光明,原娜,刘丽娟. 利塞膦酸钠对去卵巢大鼠正畸牙齿移动期间破骨细胞中FAK蛋白表达的影响. 现代生物医学进展. 2022(02): 244-248 .
    9. 马腾,陈德强,王卫国. 骨质疏松症与甲状腺功能亢进的关系. 中国骨质疏松杂志. 2022(03): 380-385+439 .
    10. 孙雅嘉,孙九许,侯思瀚,燕梦云,裴凌鹏. 基于网络药理学和分子对接探讨刺老苞防治骨质疏松症的作用机制. 食品工业科技. 2022(08): 11-21 .
    11. 许颖,付纪源,王雨情,吴健,刘冰,陈宁,于蕾,刘颖杰,李文兰. 基于网络药理学和分子对接探讨中药赤芍抗胃癌的作用机制. 特产研究. 2022(02): 81-89 .
    12. 范吉林,朱婷婷,田晓玲,薛振宇,郭经奇,任雯庆,张世亮. 基于生物信息学探讨肥胖与高血压的关系. 中华高血压杂志. 2022(04): 352-358 .
    13. 赵继荣,杨涛,陈祁青,马同,赵宁,薛旭,郭培尧,李玮农,张立存. 基于网络药理学及分子对接探讨杜仲叶防治骨质疏松的作用机制. 世界中医药. 2022(05): 664-670 .
    14. 张郁,张发雪,张寒,薛瑶珺,周广文,张妍,熊梦欣,向楠,朱伟. 基于多组学技术探讨补肾化痰方防止绝经后骨质疏松症的作用机制. 湖北中医药大学学报. 2022(05): 48-53 .
    15. 上官文姬,张跃辉,岳江,汤璐敏,张秋琪,宋佳,邵将. 柚皮苷通过HIF-1α/VEGF信号促进H型血管抗骨质疏松的研究. 中国骨质疏松杂志. 2022(12): 1755-1759 .
    16. 王剑虹,董万涛,宋敏,赵张凯,常茹梦,张杰,巩彦龙,赵楠. “缺氧-高糖”轴对糖尿病性骨质疏松症的影响机制. 中国骨质疏松杂志. 2022(11): 1634-1639 .
    17. 肖方骏,陈树东,栾继耀,侯宇,何坤,林定坤. 丹参干预骨质疏松症:网络药理学解释的作用机制. 中国组织工程研究. 2021(05): 772-778 .
    18. 邸学士,陈昭,贾育松,李晋玉,郑晨颖,白春晓,张帆,刘楚吟,袁巧妹,龙水文,冉宇,康晟乾,陈江. 基于网络药理学探讨青娥丸治疗绝经后骨质疏松症的作用机制. 中国骨质疏松杂志. 2021(03): 364-371 .
    19. 陈衎,唐金艳,马晓蓉,韩璐. 左归饮“异病同治”早发性卵巢功能不全、闭经、绝经综合征的网络药理学研究. 新疆医科大学学报. 2021(06): 744-752 .
    20. 温明韬,梁学振,李嘉程,李刚,许波. 基于网络药理学与分子对接技术探讨六味地黄丸抗骨质疏松症的机制研究. 中国骨质疏松杂志. 2021(08): 1129-1134+1153 .
    21. 马腾,陈德强,王卫国. 骨质疏松症与慢性心力衰竭的关系. 中国骨质疏松杂志. 2021(08): 1154-1158+1173 .
    22. 商海滨,廉由之,郭海玲,杨光月,邓真,艾有利,陈蓓,李国中,赵咏芳. 基于生物信息学探讨骨质疏松症与肌少症的关系. 中国骨质疏松杂志. 2021(10): 1458-1463 .
    23. 卢汪钰,李卢,孔赏,李明东,吴欢,马虎升,吴晓阳. 基于网络药理学及分子对接技术探究驻春胶囊治疗骨质疏松症的作用机制. 中医临床研究. 2021(26): 11-18 .
    24. 李慧文,曾令烽,陈海云. 基于网络药理学探讨菟丝子、女贞子治疗绝经后骨质疏松症的作用机制. 医学综述. 2021(23): 4746-4753 .
    25. 冯蓬,甘东浩,王卫国,陈德强. 基于网络药理学的熟地黄干预骨质疏松症分子机制研究. 山东中医杂志. 2020(02): 177-184 .
    26. 陶柱萍,韦桂宁,王雪雪,厉颖,尹爱武,李灿委,范孟然,巫秀美,张成桂,高鹏飞. 卵巢摘除诱导围绝经期综合征动物模型的研究进展. 中国实验动物学报. 2020(02): 260-266 .
    27. 马江涛,万雷,黄宏兴. 基于网络药理学探讨骨碎补治疗骨质疏松症的作用机制. 中国骨质疏松杂志. 2020(04): 490-496 .
    28. 史佩玉,高帅,綦向军,莫嘉浩,张唤唤,朱俊霞,陈国铭,林樫,方彩珊,徐福平. 基于网络药理学探讨二仙汤治疗骨质疏松症作用机制. 中国骨质疏松杂志. 2020(05): 702-709+736 .
    29. 邓荣,唐本夫,钟欣欣. 基于网络药理学研究黄芪抗骨质疏松作用机制. 中医药临床杂志. 2020(05): 890-896 .
    30. 张润桐,吴海宁,于桂红,周园里,贾晓斌,封亮. 基于网络药理学的淫羊藿防治疾病的优效组分及信号通路研究. 中国中药杂志. 2018(23): 4709-4717 .
    31. 徐森楠,庄莉,翟园园,姚卫峰,徐佳,刘其南,包贝华,曹雨诞,张丽,丁安伟. 基于网络药理学研究二至丸防治骨质疏松症的物质基础与作用机制. 中国药学杂志. 2018(22): 1913-1920 .
    32. 齐晓宇,安英杰. 口腔颌面部淋巴瘤患者HIF-1α及CD44v6的表达与侵袭、转移的相关性. 中国当代医药. 2018(35): 119-121 .

    Other cited types(10)

Catalog

    Article views (2820) PDF downloads (40) Cited by(42)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return